A new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug, U.S. regulators announced Wednesday.

The U.S. Food and Drug Administration approved Eli Lilly’s drug, named Zepbound. The drug, also known as tirzepatide, helped dieters lose as much as 40 to 60 pounds in testing.

  • Zozano@aussie.zone
    link
    fedilink
    arrow-up
    2
    ·
    1 year ago

    Getting Arch set up from scratch is a great learning experience. I recommend everyone to at least try to install it once properly, you’ll definitely come away with a better understanding of the system.